Table 1.
Clinical characteristics | — | TCGA | % | ICGC | % | GEO | % |
---|---|---|---|---|---|---|---|
— | — | 370 | — | 232 | — | 221 | |
Survival status | Survival | 244 | 65.95 | 189 | 81.47 | 136 | 61.5 |
Death | 126 | 34.05 | 43 | 18.53 | 85 | 38.5 | |
| |||||||
Age | ≤65 years | 232 | 62.70 | 90 | 38.79 | 200 | 90.5 |
>65 years | 138 | 37.30 | 142 | 61.21 | 21 | 9.5 | |
| |||||||
Gender | Male | 249 | 67.30 | 171 | 73.71 | 191 | 86.4 |
Female | 121 | 32.70 | 61 | 26.29 | 30 | 13.6 | |
| |||||||
Histological grade | G1 | 55 | 14.86 | NA | — | NA | — |
G2 | 177 | 47.84 | NA | — | NA | — | |
G3 | 121 | 32.70 | NA | — | NA | — | |
G4 | 12 | 3.24 | NA | — | NA | — | |
| |||||||
Stage | I | 171 | 46.22 | 36 | 15.52 | 93 | 42.1 |
II | 85 | 22.97 | 106 | 15.69 | 77 | 34.8 | |
III | 85 | 22.97 | 71 | 30.60 | 50 | 22.6 | |
IV | 5 | 1.35 | 19 | 8.19 | NA | 0.5 | |
| |||||||
T classification | T1 | 181 | 48.92 | NA | — | NA | — |
T2 | 93 | 25.14 | NA | — | NA | — | |
T3 | 80 | 21.62 | NA | — | NA | — | |
T4 | 13 | 3.51 | NA | — | NA | — | |
TX | 1 | 0.27 | NA | — | NA | — | |
| |||||||
M classification | M0 | 266 | 71.89 | NA | — | NA | — |
M1 | 4 | 1.08 | NA | — | NA | — | |
MX | 100 | 27.03 | NA | — | NA | — | |
| |||||||
N classification | N0 | 252 | 68.11 | NA | — | NA | — |
N1 | 4 | 1.08 | NA | — | NA | — | |
NX | 113 | 30.54 | NA | — | NA | — | |
| |||||||
Prior malignancy | No | NA | NA | 202 | 87.07 | NA | — |
Yes | NA | NA | 30 | 12.93 | NA | — | |
| |||||||
Tumor size | Small | NA | — | NA | — | 140 | 63.3 |
Large | NA | — | NA | — | 80 | 36.2 | |
| |||||||
Cirrhosis | No | NA | — | NA | — | 18 | 8.1 |
Yes | NA | — | NA | — | 203 | 91.9 |